Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Aquestive Therapeutics Affirms FY2025 Sales Guidance of $44.000M-$50.000M vs $45.059M Est

Author: Benzinga Newsdesk | August 11, 2025 03:02pm
Aquestive Therapeutics (NASDAQ:AQST) affirms FY2025 sales outlook from $44.000 million-$50.000 million to $44.000 million-$50.000 million vs $45.059 million estimate.

Posted In: AQST


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist